September 7, 2018—BD (Becton, Dickinson and Company) announced that is has received FDA approval for the 220-mm length of its Lutonix 035 drug-coated balloon (DCB) for the treatment of long superficial femoral artery (SFA) lesions in patients with peripheral artery disease (PAD).
“The new longer lengths of the Lutonix 035 DCB represent a tremendous opportunity for physicians to enhance their PAD treatment in long lesions with a proven technology that will now require fewer DCBs and fewer inflations, reducing DCB healthcare expenditures overall,” commented vascular surgeon Chad Laurich, MD, in the company's announcement.
BD noted that in the Lutonix Global SFA Real-World Registry, 22% of the femoropopliteal lesions were longer than 150 mm. In some of these patients, multiple DCBs were used to cover the length of the long lesion. With the approval of the 220-mm device, more disease can be treated with a single Lutonix 035 DCB.
advertisement
Related Articles
A Physician Perspective on Collaborating With Your Hospital’s Value Analysis Committee
Speaking with a physician leader at Atrium Health’s Sanger Heart and Vascular Institute about advocating for physician device preferences and effectively communicating with key stakeholders.
With Frank R. Arko III, MD
Case Report: Aortoiliac Occlusion in a Patient With Severe Claudication
Management with covered balloon-expandable stents provides another option for complex disease.
By Ehrin J. Armstrong, MD, MSc
Case Report: Treating a Long Chronic Total Occlusion in a Patient With CLI
A personalized treatment approach to a challenging case.
By Erik Weekman, BS; Vinayak Subramanian, BS; Ivy Smith, BS; and George L. Adams, MD, MHS, FACC, FSCAI
Current Challenges for the Modern Management of PAD
An overview of contemporary and emerging practices in peripheral artery disease.
By Fanny S. Alie-Cusson, MD; and Jean M. Panneton, MD, FRCSC, FACS
Top 5 Articles From August 2018
Emerging Tools for Lytic-Free, Single-Session Treatment of Venous Thromboembolic Disease
The ClotTriever Outcomes (CLOUT) registry principal investigators share their current DVT practices and thoughts on the new study, and DVT and PE case reports are presented using the Inari Medical ClotTriever and FlowTriever Systems.
With Robert E. Beasley, MD, FSIR, FSCAI; William Marston, MD; Suman Annambhotla, MD; and Wissam A. Jaber, MD
Incidental Splenic Artery Aneurysm on CT Imaging
By Moderator: Paul J. Rochon, MD, FSIR
Panel: Vishal Kumar, MD; Kumar Madassery, MD; and Waleska M. Pabon-Ramos, MD, MPH, FSIR
Left Superficial Femoral Artery Occlusion in a Patient With an Aortobifemoral Graft
By Moderator: Ehrin J. Armstrong, MD
Panel: Steve Henao, MD, FACC, FACS; Sahil A. Parikh, MD, FACC, FSCAI; and Saher Sabri, MD, FSIR
TCAR (Transcarotid Artery Revascularization): The Next Step in the Evolution of Carotid Revascularization
By Jeffrey Jim, MD, MPHS, FACS
Carotid Occlusion With Middle Cerebral Artery Thrombus
By Moderators: Adnan H. Siddiqui, MD, PhD; and Kunal Vakharia, MD;
Panel: Ansaar T. Rai, MD, MBA; and Aquilla S. Turk, DO
Top 5 from CIToday's Current Issue
Radial Artery Access
By Ted E. Feldman, MD, MSCAI, FACC, FESC
Radial Access Best Practices in 2019
An update on procedural considerations for transradial artery access based on the most recent data.
By Linda M. Koshy, MD; Matthew Schoenfeld, MD; and Binita Shah, MD, MS
2019 CMS Reimbursement and Your Ambulatory Strategy
As trends in health care continue to move toward ambulatory surgery centers, will you be ready to take advantage of the benefits they can offer?
With Tony Lafata; Marc Toth, CMAA; and Jacob Turmell, DNP, RN, NP-C, ACNS-BC, CCRN-CMC
Navigating Complex Radial Loops
An overview on radial loops and the techniques to circumvent them.
By Shing-Chiu Wong, MD; and Salil Desai, MD
Beyond Radial: Ulnar, Snuffbox, and Palmar Branch Access
A review of the limitations of transradial access and the benefits and challenges of alternative approaches for cardiac catheterization.
